Mifepristone Induction for Fetal Demise

NCT02620904 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped unable to recruit. Projected completion was 2018 however, enrollment and recruitment were difficult. The study was terminated due to inability to enroll.

Conditions

Intrauterine Fetal Demise
Fetal Death

Interventions

DRUG: Mifepristone
DRUG: placebo

Sponsor

Montefiore Medical Center